Anti-proliferative effects of the arotinoid Ro 40-8757 on human cancer cell lines in vitro
1993
Effects of Ro 40-8757 on Human Cancer Cells
Sample size: 9
publication
Evidence: moderate
Author Information
Author(s): J.F. Eliason, F. Kaufmann, T. Tanaka, T. Tsukaguchi
Primary Institution: F. Hoffmann-La Roche A.G.
Hypothesis
Can the arotinoid Ro 40-8757 inhibit the proliferation of human cancer cell lines in vitro?
Conclusion
Ro 40-8757 inhibits the growth of various human cancer cell lines without being cytotoxic.
Supporting Evidence
- Ro 40-8757 inhibited the proliferation of all cancer cell lines tested except for two lung adenocarcinoma lines.
- The compound was not cytotoxic and did not show signs of differentiation in treated cultures.
- Proliferation inhibition was concentration and time dependent.
- Ro 40-8757 was more effective than all-trans retinoic acid in inhibiting certain cancer cell lines.
Takeaway
Ro 40-8757 is a new compound that helps slow down the growth of cancer cells without hurting them.
Methodology
The study tested Ro 40-8757 on nine different human cancer cell lines and measured cell proliferation over time.
Limitations
The study does not explore the long-term effects or the exact mechanism of action of Ro 40-8757.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website